European Award of Cooperative Innovation

  • Home
  • 2025 Application
  • About the Award
  • Previous Editions
    • 2009 Edition
    • 2012 Edition
    • 2014 Edition
    • 2017 Edition
    • 2020 Edition
  • Sponsor
  • Contact
  • Home
  • public
  • Coronavirus disease 2019

Coronavirus disease 2019

Coronavirus disease 2019

by Viktor Jan / Tuesday, 15 September 2026 / Published in public

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

  • Tweet

About Viktor Jan

What you can read next

Navigating NeoSpin Casino: essential tips for new players in the online gaming world

an award brought to you by Copa and Cogeca
with the support of Cajamar Caja Rural

  • Home
  • 2025 Application
  • About the Award
  • Previous Editions
  • Sponsor
  • Contact

Rue de Trèves 61 , 1040 Bruxelles

Tèl. : +32 (0)2/287.27.11
Fax: +32 (0)2/287.27.00

mail@copa-cogeca.eu

© 2025 Cogeca | All rights reserved. Developed by MIDA, powered by WordPress.

TOP